Home/Filings/4/0001562180-24-002952
4//SEC Filing

Thomas Monica R. 4

Accession 0001562180-24-002952

CIK 0001560241other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 4:10 PM ET

Size

5.7 KB

Accession

0001562180-24-002952

Insider Transaction Report

Form 4
Period: 2024-03-20
Thomas Monica R.
General Counsel
Transactions
  • Award

    Common Stock

    2024-03-20+37,500115,651 total
Footnotes (3)
  • [F1]Represents a restricted stock unit ("RSU") award that vests 50% on March 20, 2025 and 50% on March 20, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
  • [F3]Represents (i) 176 shares of common stock; (ii) 50,000 RSUs from award granted on May 22, 2023; (iii) 27,975 RSUs from award granted on January 3, 2024; and (iv) 37,500 RSUs from award granted on March 20, 2024.

Issuer

G1 Therapeutics, Inc.

CIK 0001560241

Entity typeother

Related Parties

1
  • filerCIK 0001978347

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:10 PM ET
Size
5.7 KB